A detailed history of First Horizon Advisors, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 637 shares of CTLT stock, worth $38,188. This represents 0.0% of its overall portfolio holdings.

Number of Shares
637
Previous 1,276 50.08%
Holding current value
$38,188
Previous $72,000 51.39%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$53.58 - $57.02 $34,237 - $36,435
-639 Reduced 50.08%
637 $35,000
Q1 2024

Apr 26, 2024

BUY
$42.56 - $59.82 $2,808 - $3,948
66 Added 5.45%
1,276 $72,000
Q4 2023

Feb 06, 2024

SELL
$32.18 - $46.57 $2,767 - $4,005
-86 Reduced 6.64%
1,210 $54,000
Q3 2023

Oct 27, 2023

BUY
$44.2 - $50.2 $2,563 - $2,911
58 Added 4.68%
1,296 $59,000
Q2 2023

Aug 03, 2023

SELL
$31.86 - $67.26 $34,982 - $73,851
-1,098 Reduced 47.0%
1,238 $53,000
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $5,452 - $8,911
120 Added 5.42%
2,336 $153,000
Q4 2022

Feb 10, 2023

SELL
$41.39 - $81.0 $18,294 - $35,802
-442 Reduced 16.63%
2,216 $99,000
Q3 2022

Nov 09, 2022

SELL
$72.36 - $113.1 $23,372 - $36,531
-323 Reduced 10.84%
2,658 $192,000
Q2 2022

Aug 02, 2022

BUY
$87.2 - $114.05 $74,468 - $97,398
854 Added 40.15%
2,981 $319,000
Q1 2022

May 10, 2022

SELL
$94.19 - $124.49 $84,676 - $111,916
-899 Reduced 29.71%
2,127 $236,000
Q4 2021

Feb 09, 2022

BUY
$119.57 - $139.07 $18,533 - $21,555
155 Added 5.4%
3,026 $387,000
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $54,475 - $71,032
-499 Reduced 14.81%
2,871 $382,000
Q3 2021

Nov 09, 2021

BUY
$109.17 - $142.35 $280,676 - $365,981
2,571 Added 321.78%
3,370 $448,000
Q2 2021

Aug 09, 2021

BUY
$100.34 - $115.69 $1,404 - $1,619
14 Added 1.78%
799 $86,000
Q1 2021

May 11, 2021

BUY
$101.51 - $125.27 $14,109 - $17,412
139 Added 21.52%
785 $82,000
Q4 2020

Feb 11, 2021

BUY
$85.88 - $105.36 $7,729 - $9,482
90 Added 16.19%
646 $67,000
Q3 2020

Nov 12, 2020

BUY
$72.74 - $92.5 $22,112 - $28,120
304 Added 120.63%
556 $47,000
Q2 2020

Jul 31, 2020

SELL
$48.02 - $79.04 $14,694 - $24,186
-306 Reduced 54.84%
252 $18,000
Q1 2020

May 05, 2020

SELL
$36.95 - $62.95 $4,581 - $7,805
-124 Reduced 18.18%
558 $28,000
Q2 2018

Aug 07, 2018

SELL
$38.72 - $42.52 $4,375 - $4,804
-113 Reduced 14.21%
682 $0
Q1 2018

May 02, 2018

BUY
$39.4 - $47.39 $6,895 - $8,293
175 Added 28.23%
795 $0
Q3 2017

Nov 09, 2017

BUY
$33.75 - $41.67 $1,012 - $1,250
30 Added 5.08%
620 $0
Q2 2017

Aug 14, 2017

BUY
N/A
590
590 $0

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.